This white paper explores the drug repurposing, where known clinical candidates or commercially approved molecules are evaluated for new targets and indications.
/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png00h.genrich/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngh.genrich2021-07-06 11:45:002021-07-06 11:45:00Azafaros appoints Stefano Portolano as CEO
With a €20m financing round under its belt, Promethera Therapeutics is poised to start its Phase IIb study for its stem cell therapy treating liver failure.
Early-stage venture capital investor Novalis Biotech has closed its Biotech Acceleration Fund at €25m to drive growth of translational medicine start-ups.
The Thermo Scientific HyPerforma GXCore Bioprocess Controller is an innovative, compact, cost-effective, open-architecture controller built for research and process development applications.
https://european-biotechnology.com/wp-content/uploads/2024/04/Rheincell.jpg3201920Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2021-06-25 09:04:372021-06-25 09:04:37Rheincell set to be acquired by Catalent
Drug repurposing trends shorten timelines
Sponsored PublicationsThis white paper explores the drug repurposing, where known clinical candidates or commercially approved molecules are evaluated for new targets and indications.
Azafaros appoints Stefano Portolano as CEO
AppointmentsDr Stefano Portolano, M.D., is the new Chief Executive Officer of Azafaros and has been appointed to the Board of Directors of the Dutch company.
NFL Biosciences goes public, raises €5m
Latest NewsFrench biopharma company NFL Biosciences has raised €5m following its IPO at Euronext Growth Paris.
Promethera bags €20m for liver failure treatment
Latest NewsWith a €20m financing round under its belt, Promethera Therapeutics is poised to start its Phase IIb study for its stem cell therapy treating liver failure.
Novalis Biotech closes biotech fund at €25m
Latest NewsEarly-stage venture capital investor Novalis Biotech has closed its Biotech Acceleration Fund at €25m to drive growth of translational medicine start-ups.
Cellink AB to take-over Discover Echo Inc
Latest NewsSwedish Cellink AB has announced a bid of $110m to take over all shares of Discover Echo Inc., 11% of which to be paid in newly issued shares.
Thermo Scientific HyPerforma GXCore Bioprocess Controller
ProductsThe Thermo Scientific HyPerforma GXCore Bioprocess Controller is an innovative, compact, cost-effective, open-architecture controller built for research and process development applications.
Rheincell set to be acquired by Catalent
Latest NewsMajor CDMO Catalent has swallowed German RheinCell Therapeutics GmbH, an iPSC specialist, to expand its offerings in cell and gene therapies.
Data protection rules may block medical progress
Latest NewsIn an effort to ban AI tools for facial recognition, the EU risks to block European medical geneticists to recognise genetic diseases.
AFB strengthens finance division
AppointmentsAt the beginning of June, Sidonie Fabre strengthens Advent France Biotechnology (AFB) as new Chief Financial Officer.